Tag: M.W=200-350

Micucci, Matteo published the artcileCastanea sativa Mill. bark extract cardiovascular effects in a rat model of high-fat diet, HPLC of Formula: 21829-25-4, the main research area is Castanea sativa cardiovascular effect high fat diet Ellagitannin; cholinergic receptor; chronotropy; hydrolysable tannins; inotropy; oxydative stress; vascular relaxation.

Ellagitannins may have a beneficial impact in cardiovascular diseases. The aim of the study was to evaluate the effect of high-fat diet (HFD) and the efficacy of Castanea sativa Mill. bark extract (ENC) on cardiac and vascular parameters. Rats were fed with regular diet, (RD, n = 15), HFD (n = 15), RD + ENC (20 mg/kg/day by gavage, n = 15), and HFD + ENC (same dose, n = 15) and the effects on body weight, biochem. serum parameters, and inflammatory cytokines determined Cardiac functional parameters and aorta contractility were also assessed on isolated atria and aorta. Results showed that ENC reduced weight gain and serum lipids induced by HFD. In in vitro assays, HFD decreased the contraction force of left atrium, increased right atrium chronotropy, and decreased aorta K+-induced contraction; ENC induced transient pos. inotropic and neg. chronotropic effects on isolated atria from RD and HFD rats and a spasmolytic effect on aorta. In ex vivo experiments, ENC reverted inotropic and chronotropic changes induced by HFD and enhanced Nifedipine effect more on aorta than on heart. In conclusion, ENC restores metabolic dysfunction and cardiac cholinergic muscarinic receptor function, and exerts spasmolytic effect on aorta in HFD rats, highlighting its potential as nutraceutical tool in obesity.

Phytotherapy Research published new progress about Aorta. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, HPLC of Formula: 21829-25-4.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Adeyemi, Oladipupo published the artcileA pharmacological characterization of electrocardiogram PR and QRS intervals in conscious telemetered rats, Application In Synthesis of 21829-25-4, the main research area is ECG pharmacol agent radiotelemetry; Diltiazem; Electrocardiogram; Flecainide; Methods; Nifedipine; Quinidine; Rat; Telemetry; Translation; Verapamil.

The current study aimed to identify its utility in assessing ECG (ECG) PR and QRS interval changes. Male Han-Wistar rats (~250 g) were implanted with radio-telemetry devices for the recording of ECG and haemodynamic parameters. Animals (n = 4-8) were treated with single doses of calcium (nifedipine, diltiazem or verapamil; CCBs) or sodium channel blockers (quinidine or flecainide; SCBs) or their corresponding vehicles in an ascending dose design. Pharmacokinetic anal. of blood samples was performed to allow comparison of effects to published data in other species. Of the CCBs, only diltiazem (300 mg/kg) prolonged the PR interval (49 ± 2 vs. vehicle: 43 ± 1 ms), although this was not statistically significant (p = .11). QA interval decreased with nifedipine (30 ± 1 vs. 24 ± 0 ms) and diltiazem (34 ± 1 vs. 27 ± 1 ms) but increased with verapamil (30 ± 0 vs. 37 ± 1 ms) demonstrating pharmacol. activity of each agent. Both SCBs, caused statistically significant (p < .05) increases in both intervals - quinidine (100 mg/kg; PR: 50 ± 2 vs. 43 ± 1 ms; QRS: 22 ± 2 vs. 18 ± 1 ms) and flecainide (9 mg/kg; PR: 56 ± 1 vs. 46 ± 1 ms; QRS: 27 ± 1 vs. 21 ± 1 ms). At similar plasma concentrations to other species, the conscious telemetered rat demonstrates limited utility in assessing PR interval prolongation by CCBs, despite significant contractility effects being observed However, results with SCBs demonstrate a potential application for evaluating drug-induced QRS prolongation. Journal of Pharmacological and Toxicological Methods published new progress about Blood. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Application In Synthesis of 21829-25-4.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Kim, Hyung Min published the artcileSimultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry, Name: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, the main research area is blood cardiovascular drug amlodipine atenolol atorvastatin digoxin LC MS; Cardiovascular drugs; Dried blood spot; LC-MS/MS; Therapeutic drug monitoring.

A dried blood spot (DBS) sampling method was exploited to extract cardiovascular drugs using a small volume of whole blood of human and rodent. Thereafter, an anal. method using liquid chromatog. with tandem mass spectrometry (LC-MS/MS) was developed and validated for the determination of 12 cardiovascular drugs. A 6 mm internal diameter disk containing 10μL of blood was punched from a specifically designed card and analyzed by LC-MS/MS using a gradient elution method with a total run time of 16 min. For sample separation, a universal octadecyl-silica column was used with a flow rate of 0.2 mL/min. The developed method was validated in terms of linearity, accuracy, and precision, which showed satisfactory results. In addition, the matrix effects were closely investigated to confirm the extraction efficiency. Addnl., the stability was tested by storing DBSs at room temperature; the results showed that these drugs were stable for at least 30 days. Accordingly, the proposed LC-MS/MS method is capable to analyze several cardiovascular drugs in a single anal. It can be applied to therapeutic drug monitoring in patients as well as in the in vivo settings.

Journal of Food and Drug Analysis published new progress about Blood. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Name: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Cornelissen, Lisa G. H. published the artcileThe diagnostic value of fetal fibronectin testing in clinical practice, Product Details of C17H18N2O6, the main research area is fetal fibronectin testing diagnostic value; cervical length; cervical length measurement; fetal fibronectin; preterm delivery.

To evaluate the clin. management to withhold treatment for preterm labor in symptomatic women with an intermediate cervical length and neg. fetal fibronectin (fFN) testing. A retrospective cohort study was performed in a tertiary care teaching hospital in the Netherlands. Pregnant women with a gestational age between 23+5 to 34+0 weeks, with the presence of regular uterine contractions accompanied by a cervical length between 15 and 30 mm and intact membranes, who underwent fFN testing were included to obtain the diagnostic value of fFN testing for preterm delivery within 7 days. Fetal fibronectin testing has an extremely high neg. predictive value (100%) and sensitivity (100%) for delivery within 7 days, in singleton and multiple pregnancies. However, specificity (64%) and pos. predictive value (10%) of fFN testing in singleton pregnancies are low. Blood present on the fFN sample does not affect the reliability of the fFN test; the neg. predictive value remains 100%. Women with symptoms of early preterm labor, intact membranes, a cervical length between 15 and 30 mm and neg. fFN testing do not deliver within 7 days. Administration of corticosteroids and tocolytics can safely be withhold. Furthermore, blood on the fFN sample does not change the reliability of the fFN test.

Journal of Obstetrics and Gynaecology Research published new progress about Blood. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Product Details of C17H18N2O6.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Rousset, Matthieu published the artcileMammalian Brain Ca2+ Channel Activity Transplanted into Xenopus laevis Oocytes, Quality Control of 21829-25-4, the main research area is calcium channel Xenopus laevis oocyte mammalian brain; CaV2 Ca2+ channels; channelopathies; membrane microtransplantation; voltage clamp.

Several mutations on neuronal voltage-gated Ca2+ channels (VGCC) have been shown to cause neurol. disorders and contribute to the initiation of epileptic seizures, migraines, or cerebellar degeneration. Anal. of the functional consequences of these mutations mainly uses heterologously expressed mutated channels or transgenic mice which mimic these pathologies, since direct electrophysiol. approaches on brain samples are not easily feasible. We demonstrate that mammalian voltage-gated Ca2+ channels from membrane preparation can be microtransplanted into Xenopus oocytes and can conserve their activity. This method, originally described to study the alteration of GABA receptors in human brain samples, allows the recording of the activity of membrane receptors and channels with their native post-translational processing, membrane environment, and regulatory subunits. The use of hippocampal, cerebellar, or cardiac membrane preparation displayed different efficacy for transplanted Ca2+ channel activity. This technique, now extended to the recording of Ca2+ channel activity, may therefore be useful in order to analyze the calcium signature of membrane preparations from unfixed human brain samples or normal and transgenic mice.

Membranes (Basel, Switzerland) published new progress about Brain. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Quality Control of 21829-25-4.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Chatzistavraki, Maria published the artcileAmyloid β-protein precursor regulates depolarization-induced calcium-mediated synaptic signaling in brain slices, SDS of cas: 21829-25-4, the main research area is amyloid protein depolarization calcium signaling brain slice; Alzheimer’s disease; AβPP; amyloid-β protein precursor; calcium; neuronal signaling; synapse.

Coordinated calcium influx upon neuronal depolarization activates pathways that phosphorylate CaMKII, ERKs, and the transcription factor CREB and, therefore, expression of pro-survival and neuroprotective genes. Recent evidence indicates that amyloid-β protein precursor (AβPP) is trafficked to synapses and promotes their formation. At the synapse, AβPP interacts with synaptic proteins involved in vesicle exocytosis and affects calcium channel function. Herein, we examined the role of AβPP in depolarization-induced calcium-mediated signaling using acute cerebral slices from wild-type C57bl/6 mice and AβPP-/- C57bl/6 mice. Depolarization of acute cerebral slices from wild-type C57bl/6 and AβPP-/- C57bl/6 mice was used to induce synaptic signaling. Protein levels were examined by western blot and calcium dynamics were assessed using primary neuronal cultures. In the absence of AβPP, decreased pCaMKII and pERKs levels were observed This decrease was sensitive to the inhibition of N- and P/Q-type Voltage Gated Calcium Channels (N- and P/Q-VGCCs) by ω-conotoxin GVIA and ω-conotoxin MVIIC, resp., but not to inhibition of L-type VGCCs by nifedipine. However, the absence of AβPP did not result in a statistically significant decrease of pCREB, which is a known substrate of pERKs. Finally, using calcium imaging, we found that down regulation of AβPP in cortical neurons results in a decreased response to depolarization and altered kinetics of calcium response. AβPP regulates synaptic activity-mediated neuronal signaling by affecting N- and P/Q-VGCCs.

Journal of Alzheimer’s Disease published new progress about Brain. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, SDS of cas: 21829-25-4.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Zhao, Lixiang published the artcileElectrospun fixed dose combination fibers for the treatment of cardiovascular disease, Category: pyridine-derivatives, the main research area is electrospun fibers cardiovascular disease; Amorphous solid dispersion; Electrospinning; Fixed dose combination; Nanofiber; Nifedipine; Spironolactone.

Fixed dose combinations (FDCs) offer an accessible way to simplify complex therapeutic regimens by the simultaneous presentation of multiple drugs in a single entity to the patient. However, encapsulation of hydrophobic drugs into FDCs possess a number of tech. challenges. Electrospinning comprises a convenient way to incorporate multiple hydrophobic drugs into a single formulation in a single step, via the use of an appropriate organic solvent system during fabrication. In this study, we report a series of novel fiber formulations comprising Et cellulose loaded with two hydrophobic drugs, spironolactone and nifedipine, either individually or in combination. The drugs are found to be present in the fibers in the form of amorphous solid dispersions, and these are stable at room temperature for 4 mo. The products showed extended release profiles over more than 30 h. This formulation strategy offers potential to manage chronic cardiovascular conditions and overcome patient related non-adherence by providing a simplified treatment model.

International Journal of Pharmaceutics (Amsterdam, Netherlands) published new progress about Drugs. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Category: pyridine-derivatives.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Zhao, Junli published the artcileBerberine mediated positive inotropic effects on rat hearts via a Ca2+-dependent mechanism, Category: pyridine-derivatives, the main research area is berberine inotropic agent heart calcium; Ca2+; Na+; berberine; heart; positive inotropic effect.

Previous studies showed that berberine, an alkaloid from Coptis Chinensis Franch, might exert a pos. inotropic effect on the heart. However, the underlying mechanisms were unclear. Here, we reported that berberine at 10-20μM increased the left ventricular (LV) developed pressure and the maximal rate of the pressure rising, and it increased the maximal rate of the pressure descending at 20μM in Langendorff-perfused isolated rat hearts. These effects diminished with the concentration of berberine increasing to 50μM. In the concentration range of 50-300μM, berberine increased the isometric tension of isolated left ventricular muscle (LVM) strips with or without elec. stimulations, and it (30-300μM) also increased the intracellular Ca2+ level in the isolated LV myocytes. The removal of extracellular Ca2+ hindered the berberine-induced increases in the tension of LVM strips and the intracellular Ca2+ level of LV myocytes. These suggested that berberine might exert its pos. inotropic effects via enhancing Ca2+ influx. The blockade of L-type Ca2+ channels (LTCCs) with nifedipine significantly attenuated 300 mM berberine-induced tension increase in LVM strips but not the increase in the intracellular Ca2+ level. Berberine (300 mM) further increased the LVM tension following the treatment with the LTCC opener FPL-64716 (10 mM), indicating an LTCC-independent effect of berberine. Lowering extracellular Na+ attenuated the berberine-induced increases in both the tension of LVM strips and the intracellular Ca2+ level of LV myocytes. In conclusion, berberine might exert a pos. inotropic effect on the isolated rat heart by enhancing the Ca2+ influx in LV myocytes; these were extracellular Na+ -dependent.

Frontiers in Pharmacology published new progress about Heart. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Category: pyridine-derivatives.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Mohammed, Atyaf Hasan published the artcileA comparative study among effects of treatment with nifedipine, verapamil, diazepam or alpha-methyldopa on platelets count and behavior in women with preeclampsia, COA of Formula: C17H18N2O6, the main research area is preeclampsia nifedipine verapamil diazepam alpha methyldopa platelet behavior.

This study was conducted to investigate the role of platelets -count and -be- havior in the pathogenesis of mild and moderate preeclampsia (PE). Also, the effects of the specific treatment regimen in both cases of preeclampsia inves- tigated. In mild PE only nifedipine had significantly higher platelet count compared to those without treatment, while in moderate PE both verapamil and nifedipine had significantly higher platelet count compared to those without treatment. Concerning platelet response to ADP; in mild PE all drugs show an increase in response compared to those without treatment, a similar finding reported in moderate. While platelet response to collagen, in mild PE both diazepam and verapamil show increased response compared to those without treatment, in moderate PE methyldopa and verapamil show in- creased response compared to those without treatment. In conclusion, plate- lets may be involved in the pathogenesis of preeclampsia. Nifedipine and ve- rapamil produced effective enhancement of ex vivo platelets aggregation-in- duced by ADP or collagen and may evolve as antiplatelet agents that able to prevent the in vivo activation of platelets and exhaustion cycle, an action which could explain the observed effectiveness of calcium channel blockers for the prevention and treatment of preeclampsia other than diazepam or al- pha-methyldopa used in this study.

International Journal of Research in Pharmaceutical Sciences (Madurai, India) published new progress about Behavior. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, COA of Formula: C17H18N2O6.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

van Winden, Tms published the artcileEffects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial, Name: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, the main research area is nifedipine atosiban preterm birth; Atosiban; behaviour; child; development; executive function; follow-up; health; infant; neurodevelopment; nifedipine; preterm birth; preterm labour; tocolysis.

Objective : To compare the long-term effects of tocolysis with nifedipine or atosiban on child outcome at age 2.5-5.5 years. Design : The APOSTEL III trial was a multicentre randomised controlled trial that compared tocolysis with nifedipine or atosiban in 503 women with threatened preterm birth. Methods : Parents were asked to complete four questionnaires regarding neurodevelopment, executive function, behavior problems and general health. Main outcome measures : The main long-term outcome measure was a composite of abnormal development at the age of 2.5-5.5 years. Results : Of the 426 women eligible for follow-up, 196 parents returned the questionnaires for 115 children in the nifedipine group and 110 children in the atosiban group. Abnormal development occurred in 32 children in the nifedipine group and in 38 children in the atosiban group (OR 0.74, 95% CI 0.41-1.34). Sensitivity anal. for all children of the APOSTEL III trial, including a comparison of deceased children, resulted in a higher rate of healthy survival in the nifedipine group (64 vs. 54%), but there was no significant difference in the overall mortality rate (5.4 vs. 2.7%). Conclusion : Outcomes on broad child neurodevelopment, executive function, behavior and general health were comparable in both groups. Tweetable abstract : Nifedipine- and atosiban-exposed children had comparable long-term outcomes, including neurodevelopment, executive function and behavior.

BJOG published new progress about Behavior. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Name: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem